Gsk (GSK) Share-based Compensation (2009 - 2015)

Gsk (GSK) has 7 years of Share-based Compensation data on file, last reported at $558.4 million in Q4 2015.

• For the quarter ending Q4 2015, Share-based Compensation rose 6.16% year-over-year to $558.4 million; the trailing twelve-month figure through Dec 2015 stood at $2.0 billion (up 14.49% YoY), and the FY2023 full-year result was $381.9 million, down 10.83% from the prior year.
• Share-based Compensation was $558.4 million for Q4 2015 at Gsk, up from $526.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $558.4 million in Q4 2015 to a low of $311.2 million in Q4 2011.
• A 5-year average of $453.1 million and a median of $516.5 million in 2013 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation jumped 46.19% in 2013 and advanced 1.85% in 2014, its largest moves.
• Gsk's Share-based Compensation stood at $311.2 million in 2011, then advanced by 13.54% to $353.3 million in 2012, then surged by 46.19% to $516.5 million in 2013, then advanced by 1.85% to $526.0 million in 2014, then grew by 6.16% to $558.4 million in 2015.
• Per Business Quant data, the three most recent Share-based Compensation figures were $558.4 million in Q4 2015, $526.0 million in Q4 2014, and $516.5 million in Q4 2013.